252 related articles for article (PubMed ID: 22407480)
1. An industrial perspective on contemporary applications of PBPK models in drug discovery and development.
Smith BJ
Biopharm Drug Dispos; 2012 Mar; 33(2):53-4. PubMed ID: 22407480
[No Abstract] [Full Text] [Related]
2. Physiologically based pharmacokinetic (PBPK) modeling: it is here to stay!
Rostami-Hodjegan A; Tamai I; Pang KS
Biopharm Drug Dispos; 2012 Mar; 33(2):47-50. PubMed ID: 22351594
[No Abstract] [Full Text] [Related]
3. Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective.
Jones HM; Chen Y; Gibson C; Heimbach T; Parrott N; Peters SA; Snoeys J; Upreti VV; Zheng M; Hall SD
Clin Pharmacol Ther; 2015 Mar; 97(3):247-62. PubMed ID: 25670209
[TBL] [Abstract][Full Text] [Related]
4. The role of discovery DMPK scientists in industry: where do we go from here?
Moriwaki T
Drug Metab Pharmacokinet; 2012; 27(2):169-70. PubMed ID: 22531680
[No Abstract] [Full Text] [Related]
5. Drug discovery in the next decade: innovation needed ASAP.
Bennani YL
Drug Discov Today; 2011 Sep; 16(17-18):779-92. PubMed ID: 21704185
[TBL] [Abstract][Full Text] [Related]
6. Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies.
Chen Y; Jin JY; Mukadam S; Malhi V; Kenny JR
Biopharm Drug Dispos; 2012 Mar; 33(2):85-98. PubMed ID: 22228214
[TBL] [Abstract][Full Text] [Related]
7. Virtual drug discovery with the rise of Chinese CROs.
Zhang MQ
Drug Discov Today; 2010 Sep; 15(17-18):693-7. PubMed ID: 20685343
[No Abstract] [Full Text] [Related]
8. Developing pharmacogenetic evidence throughout clinical development.
Burns DK
Clin Pharmacol Ther; 2010 Dec; 88(6):867-70. PubMed ID: 20981004
[TBL] [Abstract][Full Text] [Related]
9. The long march of antisense.
Jones D
Nat Rev Drug Discov; 2011 Jun; 10(6):401-2. PubMed ID: 21629279
[No Abstract] [Full Text] [Related]
10. 2011 in reflection.
Mullard A
Nat Rev Drug Discov; 2012 Jan; 11(1):6-8. PubMed ID: 22212664
[No Abstract] [Full Text] [Related]
11. The future is much closer collaboration between the pharmaceutical industry and academic medical centers.
Vallance P; Williams P; Dollery C
Clin Pharmacol Ther; 2010 May; 87(5):525-7. PubMed ID: 20407455
[No Abstract] [Full Text] [Related]
12. Partnering for therapeutics discovery.
Colvis CM; Devaney S; Brady LS; Hudson KL
Clin Pharmacol Ther; 2013 Jan; 93(1):24-5. PubMed ID: 23187876
[No Abstract] [Full Text] [Related]
13. From preclinical to human--prediction of oral absorption and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: a workflow by using case example.
Sinha VK; Snoeys J; Osselaer NV; Peer AV; Mackie C; Heald D
Biopharm Drug Dispos; 2012 Mar; 33(2):111-21. PubMed ID: 22383166
[TBL] [Abstract][Full Text] [Related]
14. How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development.
Perakslis ED; Van Dam J; Szalma S
Clin Pharmacol Ther; 2010 May; 87(5):614-6. PubMed ID: 20376001
[No Abstract] [Full Text] [Related]
15. Modern phenotypic drug discovery is a viable, neoclassic pharma strategy.
Lee JA; Uhlik MT; Moxham CM; Tomandl D; Sall DJ
J Med Chem; 2012 May; 55(10):4527-38. PubMed ID: 22409666
[No Abstract] [Full Text] [Related]
16. Could pharma open its drug freezers?
Mullard A
Nat Rev Drug Discov; 2011 Jun; 10(6):399-400. PubMed ID: 21629278
[No Abstract] [Full Text] [Related]
17. The risky business of drug development in neurology.
Craven R
Lancet Neurol; 2011 Feb; 10(2):116-7. PubMed ID: 21256451
[No Abstract] [Full Text] [Related]
18. Picking up the pieces with FBDD or FADD: invest early for future success.
Whittaker M
Drug Discov Today; 2009 Jul; 14(13-14):623-4. PubMed ID: 19486947
[No Abstract] [Full Text] [Related]
19. The role of discovery DMPK scientists in industry: where do we go from here?
Moriwaki T
Drug Metab Pharmacokinet; 2012; 27(2):169-70. PubMed ID: 22666880
[No Abstract] [Full Text] [Related]
20. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
Napper AD
IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
